Pneumococcal vaccine vs control vaccine
- Pneumococcal vaccination during pregnancy for preventing infant infection 2015 · Cochrane Headline outcomes onlyno estimate extracted0 participantsGRADE not reported
Pneumococcal vaccine showed no clear difference in neonatal infection ‐ Pneumonia compared with control vaccine (low certainty).
Pneumococcal vaccine showed no clear difference in neonatal infection ‐ Meningitis compared with control vaccine (low certainty).
Pneumococcal vaccine showed no clear difference in neonatal infection ‐ Otitis media compared with control vaccine (low certainty).
Pneumococcal vaccine showed no clear difference in neonatal infection ‐ All infections compared with control vaccine (low certainty).
Pneumococcal vaccine showed no clear difference in pneumococcal colonization ‐ At 2‐3 months of age compared with control vaccine (low certainty).
Pneumococcal vaccine showed no clear difference in pneumococcal colonization ‐ By 6‐7 months of age compared with control vaccine (low certainty).
Respiratory syncytial virus vaccine leads to lower infant hospitalisation with laboratory‐confirmed RSV disease compared with placebo (high certainty).
The review found no eligible studies for this question.
Respiratory syncytial virus vaccine showed no clear difference in intrauterine growth restriction compared with placebo (moderate certainty).
Respiratory syncytial virus vaccine showed no clear difference in stillbirth compared with placebo (low certainty).
Respiratory syncytial virus vaccine showed no clear difference in maternal death compared with placebo (low certainty).
It is very uncertain whether respiratory syncytial virus vaccine changes preterm birth compared with placebo (very low certainty).
Respiratory syncytial virus vaccine showed no clear difference in congenital abnormalities compared with placebo (high certainty).
It is very uncertain whether respiratory syncytial virus vaccine changes infant death compared with placebo (very low certainty).
Viral influenza vaccine showed no clear difference in maternal death compared with control (moderate certainty).
Viral influenza vaccine showed no clear difference in infant death (up to 175 days) compared with control (moderate certainty).
Viral influenza vaccine showed no clear difference in perinatal death (stillbirth + death in first week of life) compared with control (moderate certainty).
Viral influenza vaccine showed no clear difference in any respiratory illness in women compared with control (high certainty).
Viral influenza vaccine showed no clear difference in any respiratory illness in infants compared with control (high certainty).